UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin

Oncogene, 2017-01, Vol.36 (2), p.254-262

2017

Volltextzugriff (PDF)

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study

Thrombosis research, 2020-01, Vol.185, p.13-19

2020

Volltextzugriff (PDF)

Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19]

Thrombosis research, 2020-07, Vol.191, p.156-159

2020

Volltextzugriff (PDF)

PB0510 Primary Care Clinician Perceptions and Use of Reduced-Dose Direct Oral Anticoagulants for Extended Phase Venous Thromboembolism Treatment

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101872, Article 101872

2023

Volltextzugriff (PDF)

A3 FELLOWS CASE CONFERENCE: Peripheral T Cell Lymphoma Masquerading As Asthma And Eosinophilia

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

Frequency of Kras mutation in colorectal cancer patients in a minority-based population at a community clinical oncology program (CCOP)–participating inner-city hospital

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14051-e14051

2011

Volltextzugriff (PDF)

Frequency distribution of hepatitis C infection among patients with B-cell non-Hodgkin lymphoma in underserved minority population

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e18536-e18536

2011

Volltextzugriff (PDF)

Clinical presentation characteristics and prognosis of urban, minority patients presenting with triple-negative breast cancer: An observational 5-year case review

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.1100-1100

2008

Volltextzugriff (PDF)

Therapeutic plasma exchange for COVID‐19‐associated hyperviscosity

Transfusion (Philadelphia, Pa.), 2021-04, Vol.61 (4), p.1029-1034

2021

Volltextzugriff (PDF)

Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019

Medicine (Baltimore), 2020-11, Vol.99 (46), p.e23186-e23186

2020

Volltextzugriff (PDF)

Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment

Research and practice in thrombosis and haemostasis, 2022-05, Vol.6 (4), p.e12740-n/a, Article e12740

2022

Volltextzugriff (PDF)

Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination

Journal of the American College of Emergency Physicians Open, 2021-10, Vol.2 (5), p.e12531-n/a

2021

Volltextzugriff (PDF)

Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment

Journal of clinical medicine, 2023-12, Vol.13 (1), p.96

2023

Volltextzugriff (PDF)

Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia

JCO oncology practice, 2021-04, Vol.17 (4), p.e497-e505

2021

Volltextzugriff (PDF)

Bleeding and Thrombosis in the Elderly

Nonmalignant Hematology, 2016, p.677-684

2016

Volltextzugriff (PDF)

Immune thrombocytopenia in 2 healthy young women after the Pfizer-BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination

Journal of the American College of Emergency Physicians open, 2021, Vol.2 (5), p.e12531-e12531

2021

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(20)

Publikationsform

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin

Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study

Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19]

PB0510 Primary Care Clinician Perceptions and Use of Reduced-Dose Direct Oral Anticoagulants for Extended Phase Venous Thromboembolism Treatment

A3 FELLOWS CASE CONFERENCE: Peripheral T Cell Lymphoma Masquerading As Asthma And Eosinophilia

Frequency of Kras mutation in colorectal cancer patients in a minority-based population at a community clinical oncology program (CCOP)–participating inner-city hospital

Frequency distribution of hepatitis C infection among patients with B-cell non-Hodgkin lymphoma in underserved minority population

Clinical presentation characteristics and prognosis of urban, minority patients presenting with triple-negative breast cancer: An observational 5-year case review

Therapeutic plasma exchange for COVID‐19‐associated hyperviscosity

Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019

Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment

Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination

Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment

Rigosertib Oral in Transfusion Dependent Lower Risk Myelodysplastic Syndromes (LR-MDS): Optimization of Dose and Rate of Transfusion Independence (TI) or Transfusion Reduction (TR) in a Single-Arm Phase 2 Study

Improving Outcomes in Elderly Acute Promyelocytic Leukemia Patients in the Real World: A Personalized Treatment Approach Along with Expert Support Might Reduce Early Deaths

Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia

A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States

A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States

Bleeding and Thrombosis in the Elderly

Immune thrombocytopenia in 2 healthy young women after the Pfizer-BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination

Suchergebnisse filtern